Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Receivables - Other (2016 - 2025)

Historic Receivables - Other for HUTCHMED (China) (HCM) over the last 12 years, with Q2 2025 value amounting to $21.5 million.

  • HUTCHMED (China)'s Receivables - Other rose 4611.25% to $21.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $21.5 million, marking a year-over-year increase of 4611.25%. This contributed to the annual value of -$3.3 million for FY2024, which is 11143.98% down from last year.
  • Per HUTCHMED (China)'s latest filing, its Receivables - Other stood at $21.5 million for Q2 2025, which was up 4611.25% from $14.7 million recorded in Q2 2024.
  • Over the past 5 years, HUTCHMED (China)'s Receivables - Other peaked at $73.0 million during Q2 2022, and registered a low of -$5.6 million during Q4 2021.
  • In the last 5 years, HUTCHMED (China)'s Receivables - Other had a median value of $25.4 million in 2023 and averaged $27.5 million.
  • In the last 5 years, HUTCHMED (China)'s Receivables - Other surged by 12739.27% in 2022 and then plummeted by 5990.91% in 2023.
  • HUTCHMED (China)'s Receivables - Other (Quarter) stood at -$5.6 million in 2021, then surged by 1405.11% to $73.0 million in 2022, then tumbled by 59.91% to $29.3 million in 2023, then plummeted by 49.75% to $14.7 million in 2024, then soared by 46.11% to $21.5 million in 2025.
  • Its last three reported values are $21.5 million in Q2 2025, $14.7 million for Q2 2024, and $29.3 million during Q2 2023.